Status:
COMPLETED
Does Placenta Pathology Predict Outcome of Neonates With Hypoxic Ischemic Encephalopathy?"
Lead Sponsor:
University Children's Hospital, Zurich
Conditions:
Asphyxia Neonatorum
Eligibility:
All Genders
1-4 years
Brief Summary
The histology of the placenta of newborn infants with perinatal asphyxia and hypoxic-ischaemic encephalopathy is analysed. There will be an evaluation if placenta could be a biomarker for neurodevelop...
Eligibility Criteria
Inclusion
- all newborn infants with APGAR \<5 at 10minutes, pH\<7.0, lactate \>12mmol/L, base excess \>16, resuscitation \>10min after birth, gestational age \>35 weeks and an encephalopathy -
Exclusion
- \-
Key Trial Info
Start Date :
January 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2017
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03284528
Start Date
January 1 2011
End Date
January 1 2017
Last Update
September 21 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Children's hospital Zurich
Zurich, Switzerland, 8044